FTX Collapse Creating Chaos as Users Ask for Regulations

 

FTX nearing bankruptcy has sent much of the crypto industry into a tailspin. The company once had a $32b evaluation and is now headed towards extinction after Binance opted out of the acquisition.

Simon Mak, Professor at Southern Methodist University in Dallas, TX, points out that these companies have sizable effects not only on the market but in the crypto technology space in general. This also begs the question of who, if anyone, is regulating the moral compass that these companies theoretically possess.

Simon’s Thoughts:

“The spirit of cryptocurrencies was to be a funding mechanism to support cool blockchain projects that solve tough and unaddressed problems in society. Now, let’s fast forward to 2022 where cryptocurrencies have now become the main focus in using blockchain for good to solve societal problems.

Why? Easy answer, and it’s the same answer as always, greed and the unmitigated pursuit of wealth without a moral compass. The nuance, however, in this answer is that in the new digital world, wealth and crime scale rapidly, specifically for blockchain. Wealth and crime began with a cohort of technologists, many of whom were educated at top-tier universities like MIT.

It is beyond shameful that there are people who have been gifted with technical superpowers and instead of using their superpowers for good, they use them to increase their personal pocketbook.”

 

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More
Immuno-Oncology
Shaping the Future of Cancer Care Through Immuno-Oncology
April 19, 2025

In the ever-evolving world of cancer treatment, immuno-oncology (IO) continues to stand at the forefront of innovation. With recent FDA approvals for TIL therapies and bispecific antibodies, and new developments in CAR-T technologies, the field is rapidly expanding into combination-based strategies that integrate with standard care. Researchers are also exploring how to overcome challenges posed…

Read More